Disparities in collaborative patient-provider communication about HPV vaccination
|
|
- Nancy Lyons
- 6 years ago
- Views:
Transcription
1 Disparities in collaborative patient-provider communication about HPV vaccination Jennifer L. Moss, PhD 1,2, Melissa B. Gilkey, PhD 3, Barbara K. Rimer, DrPH 1, Noel T. Brewer, PhD 1 1 University of North Carolina 2 National Cancer Institute 3 Harvard Medical School May 20, 2016
2 Disclosures JLM, MBG, and BKR have no potential conflicts to report. NTB has served on paid advisory boards or received research grants from Merck, GSK, CDC, and FDA, and now serves as chair of the CDC-funded National HPV Vaccination Roundtable. This research was supported by a grant from National Cancer Institute (F31 CA189411; PI: Moss) and data support from the National Center for Health Statistics. Opinions do not necessarily reflect the official positions of the NCI or the NCHS. 2
3 Introduction: HPV Infection can lead to Genital warts (>300k cases/yr in US) Cancer (26k cases/yr in US) High-priority populations Racial/ethnic minorities Un/underinsured Vaccine Lack of health disparities in uptake Suboptimal uptake overall U.S. HPV vaccine initiation, 2014 Girls 60% Boys 42% 3
4 Introduction: Patient-provider interactions Provider recommendation Communication style? Paternalistic v. collaborative Association with HPV vaccination: Mixed findings Differences in communication style by patient characteristics 4
5 Methods Collaborative communication Demographics HPV vaccine initiation National Immunization Survey-Teen, 2010 n=4,124 parents of girls Measures Collaborative communication (Charles et al., 1997, 1999, 2006) HPV vaccine initiation (verified by healthcare providers) Formal test of mediation (Iacobucci, 2012; Sobel, 1982) 5
6 Results: Participant characteristics (n=4,124) Non-Hispanic white 61% Privately insured 62% Mother with >HS degree 64% At/above poverty 78% Urban 85% 6
7 % initiating HPV vaccine Results: Communication and vaccination Overall HPV vaccine initiation: 49% 100% 80% *** OR=4.70 (95% CI= ) 60% 40% 20% 0% Non-collaborative communication Collaborative communication ***p<.001 7
8 NH White v Hispanic Private v public insur Mom > HS v mom HS At or above v below pov Urb/suburb v rural % reporting collaborative communication Results: Collaborative communication Overall prevalence = 53% 100% ** *** * ** ** 80% 60% 40% 20% 0% *p<.05 **p<.01 ***p<.001 8
9 Results: Mediation (I) Ethnicity Collaborative v non-collaborative -0.69* 1.07 Hispanic v non-hispanic white 0.56* (0.38) Vaccination v no vaccination Mediation z = -2.94* Controlling for provider recommendation for vaccination. *p<.05 9
10 Results: Mediation (II) Health insurance Collaborative v non-collaborative -0.35* 1.05* Public v private insurance 0.36* (0.28*) Vaccination v no vaccination Mediation z = -2.28* Controlling for provider recommendation for vaccination. *p<.05 10
11 Summary a = - Collaborative communication b = + Underserved groups c = ++ (c = +) HPV vaccine initiation Underserved group z -score for mediation Hispanic ethnicity -2.94* Public insurance -2.28* Below federal poverty level Spanish speaking Lower maternal education p<.10 *p<.05 11
12 Strengths and limitations Strengths Nationally-representative sample Provider-verified vaccination status Limitations Cross-sectional analysis Parental self-report of communication 12
13 Conclusions HPV vaccination Higher when parents reported collaborative communication Equal or higher in high-priority groups Evident disparities in collaborative patient-provider communication Lower in high-priority groups Disparities in communication suppressed differences in vaccination Equalizing communication styles across groups could result in more favorable vaccination outcomes overall and for high-priority groups. 13
14 Jennifer L. Moss, PhD Cancer Prevention Fellow National Cancer Moss, J. L., Gilkey, M. B., Rimer, B. K., & Brewer, N. T. (in press). Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination. Human Vaccines & Immunotherapeutics. 14
15 cpfp.cancer.gov
16 Mediation results (III): Poverty Below v above poverty level Collaborative v non-collaborative -0.42* 1.55* 0.53* (0.31) Vaccination v no vaccination Mediation z = -2.59* *p<.01 16
17 Mediation results (IV): Rurality Collaborative v non-collaborative 0.36* 1.55* Rural vs urban 0.08 (0.18) Vaccination v no vaccination Mediation z = 2.87* *p<.01
18 Percent initiating HPV vaccination Results (V.a.): Moderation % +33% Non-collaborative communication Yes Collaborative communication 10 0 Rural Moderation p=.02 Urban/suburban
19 Percent initiating HPV vaccination Results (V.b.): Moderation % +16% +40% +18% Non-collab. communication Yes Collaborative communication 10 0 Non-Hispanic white Non-Hispanic black Hispanic Other Moderation p=.01
20 Odds ratio of HPV vaccination Step 1: Demographics & vaccination Dem. Comm. Vacc. 2.5 Hispanic (v. non-hispanic white ref.) OR=1.30 Public ins. (v. private insurance ref.) OR=1.11 Below pov. level (v. at/above poverty ref.) OR= Well-served Underserved 0.0 Race/ethnicity Insurance Poverty 20
21 Odds ratio of reporting collab. comm. Step 2: Demographics & communication Dem. Comm. Vacc. 2.5 Hispanic (v. non-hispanic white ref.) OR=0.54* Public ins. (v. private insurance ref.) OR=0.63** Below pov. level (v. at/above poverty ref.) OR=0.66* Race/ethnicity Insurance Poverty Well-served Underserved *p<.01 **p<
22 Step 3: Communication & vaccination Dem. Comm. Vacc. HPV vaccination: 49% HPV vax OR (95% CI) DID NOT report collaborative communication 31% ref. DID report collaborative communication 66% 4.70 ( ) (OR is controlling for provider recommendation for vaccination) 22
23 Step 4: Demographics, communication, and vaccination a = - Collaborative communication b = + Demographics (underserved groups) c = ++ (c = +) HPV vaccination 23
24 Odds ratio of HPV vaccination Differences in vaccination odds 3.0 Hispanics (v. non-hispanic white ref.) z = -3.04* Public ins. (v. private insurance ref.) z = -3.67* Below pov. (v. at/above poverty ref.) z = -2.59* c c' c c' c c' *p<.01
Impact of school-entry requirements on adolescent vaccination coverage, timeliness, & seasonal variation
Impact of school-entry requirements on adolescent vaccination coverage, timeliness, & seasonal variation Jennifer L. Moss 1,2, Paul L. Reiter 3, Young K. Truong 1, Barbara K. Rimer 1, Noel T. Brewer 1
More informationNIH Public Access Author Manuscript Prev Med. Author manuscript; available in PMC 2014 June 05.
NIH Public Access Author Manuscript Published in final edited form as: Prev Med. 2010 April ; 50(4): 213 214. doi:10.1016/j.ypmed.2010.02.001. Vaccinating adolescent girls against human papillomavirus
More informationRisk Communication and HPV Vaccination: Fixing a Crisis in Cancer Prevention
Risk Communication and HPV Vaccination: Fixing a Crisis in Cancer Prevention Noel T. Brewer, PhD University of North Carolina Twitter: @noeltbrewer Disclosure Grants, speaker or advisory boards American
More informationCommunicating about HPV vaccination: Lessons learned from physicians and parents
Communicating about HPV vaccination: Lessons learned from physicians and parents Melissa B. Gilkey, PhD Assistant Professor of Population Medicine Harvard Medical School & Harvard Pilgrim Health Care Institute
More informationAdolescent AFIX Study: A PHSSR Approach to Improving the Delivery of HPV Vaccine
Adolescent AFIX Study: A PHSSR Approach to Improving the Delivery of HPV Vaccine Research Team Melissa Gilkey, William Calo, Jennifer MacKinnon, Jennifer Leeman, & Noel Brewer Practice Teams Nicole Freeto,
More informationVaccine Communication
Vaccine Communication Noel T. Brewer, PhD Associate Professor of Health Behavior, UNC Chair, National HPV Vaccination Roundtable Disclosures Grants, advisory boards or paid speaker American Cancer Society
More informationRyan White Program Demographic Data Fiscal Year 25
Total # of Clients Ryan White Program Demographic Data Fiscal Year 25 (3/1/2015 thru 2/29/2016) (June 6, 2016) Review of Utilization Data from the Service Delivery Information System (SDIS) Prepared by
More informationSpeaker Notes: Qualitative Methods in Dissemination and Implementation Research
Speaker Notes: Qualitative Methods in Dissemination and Implementation Research PART 3: DISSEMINATION CASE STUDY Slide 1: Dissemination Case Study Welcome to Qualitative Methods in Dissemination and Implementation
More informationResearch Project Update: AFIX Program Strategies for Improving HPV Vaccination Rates in the Field
71272GPmeeting_13: Power Point Presentation Presented by Melissa Gilkey, PhD, Assistant Professor of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute Research Project
More informationPredictors of Human Papillomavirus Vaccination in Georgia
Walden University ScholarWorks Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral Studies Collection 2017 Predictors of Human Papillomavirus Vaccination in Georgia Ashley Nash
More informationImproving HPV Vaccine Coverage Why We Must and How We Can Do Better
National Center for Immunization & Respiratory Diseases Improving HPV Vaccine Coverage Why We Must and How We Can Do Better Melinda Wharton, MD, MPH Director, Immunization Services Division Illinois State
More informationThere are two supplemental tables presented here. The first, Table A.1, compares the items in the
Appendix There are two supplemental tables presented here. The first, Table A.1, compares the items in the modified Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) to those included in the
More informationParental Attitudes toward Human Papilloma Virus Vaccine Participation of Adolescent Daughters in a Rural Population
Diversity and Equality in Health and Care (2018) 15(4): 164-168 2018 Insight Medical Publishing Group Research Article Parental Attitudes toward Human Papilloma Virus Vaccine Participation of Adolescent
More informationNIH Public Access Author Manuscript J Community Health. Author manuscript; available in PMC 2015 October 01.
NIH Public Access Author Manuscript Published in final edited form as: J Community Health. 2014 October ; 39(5): 849 856. doi:10.1007/s10900-014-9931-x. Perceptions of mailed HPV self-testing among women
More informationNIH Public Access Author Manuscript Sex Transm Dis. Author manuscript; available in PMC 2014 November 11.
NIH Public Access Author Manuscript Published in final edited form as: Sex Transm Dis. 2013 October ; 40(10): 822 828. doi:10.1097/olq.0000000000000021. Parents and Sons Beliefs in Sexual Disinhibition
More informationPresident's Cancer Panel 2014 Report HPV Vaccination: Progress and Activities
Lisa Paradis, MPH Research Analyst, President s Cancer Panel President's Cancer Panel 2014 Report HPV Vaccination: Progress and Activities Increasing HPV Vaccination in the United States: A Collaboration
More informationGender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,
Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project, 2009-2010 Linda Beer PhD, Christine L Mattson PhD, William Rodney Short MD,
More informationFactors Associated with School Nurses Encouraging HPV Vaccination
Factors Associated with School Nurses Encouraging HPV Vaccination BRITTANY L. ROSEN, PHD, CHES DARSON L. RHODES, PHD, MCHES JOSEPH VISKER, PHD, MCHES J. CHRISTIAN BANEZ BENJAMIN LASSER Objectives 1. Describe
More informationAdolescent AFIX: A Multi-state RCT to Increase Adolescent Immunization through Vaccine Provider Best Practices
Adolescent AFIX: A Multi-state RCT to Increase Adolescent Immunization through Vaccine Provider Best Practices Research In Progress Webinar Thursday, September 14, 2017 12:00-1:00pm ET/ 9:00am-10:00am
More informationUptake of 2009 H1N1 vaccine among adolescent females
Short Report Human Vaccines 7:2, 191-196; February 2011; 2011 Landes Bioscience Short Report Uptake of 2009 H1N1 vaccine among adolescent females Paul L. Reiter, 1,2, * Annie-Laurie McRee, 1 Sami L. Gottlieb,
More informationPromoting cervical health by reducing screening disparities and improving HPV vaccination utilization/uptake
ORANGE COUNTY WOMEN S HEALTH POLICY BRIEF: CERVICAL CANCER October 2014 Promoting cervical health by reducing screening disparities and improving HPV vaccination utilization/uptake EXECUTIVE SUMMARY The
More informationUsing Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers
Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers National Conference of State Legislatures Annual Meeting J August 2006 Christy Schmidt Senior Director of Policy National
More informationNIH Public Access Author Manuscript Sex Transm Infect. Author manuscript; available in PMC 2013 June 21.
NIH Public Access Author Manuscript Published in final edited form as: Sex Transm Infect. 2012 June ; 88(4): 264 265. doi:10.1136/sextrans-2011-050197. Advertisements promoting HPV vaccine for adolescent
More informationPopulation-level effectiveness & cost-effectiveness of the 9-valent HPV vaccine
Population-level effectiveness & cost-effectiveness of the 9-valent HPV vaccine Marc Brisson Canadian Research Chair Modeling Infectious Diseases Associate Professor, Université Laval PCC2015 February
More informationSection I: Executive Summary
To advance the elimination of health and health care disparities among racial/ethnic minorities and underserved populations through health equity advocacy. Subject: 2017 Annual Report Members NC Office
More informationChildren s Oral Health and Access to Dental Care in the United States
Children s Oral Health and Access to Dental Care in the United States Bruce Dye, DDS, MPH Institute of Medicine Oral Health Access to Services Meeting: 4 March 2010 U.S. DEPARTMENT OF HEALTH AND HUMAN
More informationHPV Vaccination Rates
HPV Vaccination Rates Jennifer E. Dietrich MD, MSc Fellowship Director Pediatric and Adolescent Gynecology, Division of Pediatric and Adolescent Gynecology Department of Obstetrics and Gynecology Department
More informationABSTRACT. Kanokphan Rattanawatkul, Masters of Public Health, Department of Epidemiology and Biostatistics
ABSTRACT Title of thesis: COMPLIANCE WITH AGE AT INITIATION OF HUMAN PAPILLOMAVIRUS VACCINE SERIES BY SOCIOECONOMIC STATUS, RACE/ETHNICITY, AND HEALTH INSURANCE COVERAGE AMONG 13-17 YEAR-OLD FEMALES WHO
More informationHPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION
National Center for Immunization & Respiratory Diseases HPV VACCINATION ROUTINELY RECOMMENDING CANCER PREVENTION Melinda Wharton, MD, MPH Director, Immunization Services Division Mississippi Primary Health
More informationGUIDELINES FOR POLICY PAPERS SUBMITTED TO THE HOUSE OF DELEGATES
GUIDELINES FOR POLICY PAPERS SUBMITTED TO THE HOUSE OF DELEGATES Resolution Deadline: March 20, 2018 The purpose of this document is to provide standard guidelines for the submission of policy papers to
More informationLet s Get Teens Immunized Against HPV
PAT OBULANEY, DNP, RN, ANP-C Let s Get Teens Immunized Against HPV In the US, 12,900 women diagnosed with cervical cancer yearly and 4,100 will die (CDC, 2013). Hispanic women have the highest incidence
More informationSurvival among Native American Adolescent and Young Adult Cancer Patients in California
Survival among Native American Adolescent and Young Adult Cancer Patients in California Cyllene R. Morris, 1 Yi W. Chen, 1 Arti Parikh-Patel, 1 Kenneth W. Kizer, 1 Theresa H. Keegan 2 1 California Cancer
More informationby Stephanie E. Wever June 2012
Psychosocial factors influencing HPV vaccine uptake among female adolescents in Philadelphia, PA by Stephanie E. Wever June 2012 A Community Based Master s Project presented to the faculty of Drexel University
More informationOral Health in Children in Iowa
December 2012 Oral Health in Children in Iowa An Overview From the 2010 Iowa Child and Family Household Health Survey Peter C. Damiano Director Jean C. Willard Senior Research Assistant Ki H. Park Graduate
More informationThe HPV Vaccine: Are Dosing Recommendations Being Followed?
The HPV Vaccine: Are Dosing Recommendations Being Followed? By Weiyi Tan A Master s Paper submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements
More informationAmerican Men s Internet Survey (AMIS)
American Men s Internet Survey (AMIS) Travis Sanchez, DVM, MPH Associate Research Professor Rollins School of Public Health Emory University April 17, 2014 Disclaimer: The findings and conclusions in this
More informationHPV Trends: Improving Vaccination Coverage
National Center for Immunization & Respiratory Diseases HPV Trends: Improving Vaccination Coverage Cindy Weinbaum MD MPH Acting Director, Immunization Services Division Texas Immunization Conference San
More informationHPV/Cervical Cancer Resource Guide for patients and providers
DHS: PUBLIC HEALTH DIVISION IMMUNIZATION PROGRAM HPV/Cervical Cancer Resource Guide for patients and providers Independent. Healthy. Safe. Oregon HPV Provider Resource Kit: Table of Contents Provider Information
More informationEpidemiological and survey research to characterize multi-level factors associated with HPV vaccination rates
Epidemiological and survey research to characterize multi-level factors associated with HPV vaccination rates Finney Rutten LJ, Radecki Breitkopf C, Jacobson RM Mayo Clinic, Rochester, MN 20Reminder/Recall7
More informationBeyond Seasonal Influenza
HHS Adult Immunization Task Force - Disparities Workgroup Beyond Seasonal Influenza adult immunizations(tetanus, varicella, HPV, zoster, MMR, pneumococcal, meningococcal, and hepatitis A+B) A NATION FREE
More informationUNC Family Health Study
Health Cognition & Behavior Lab Person County Pilot Study on HPV Vaccination (2006) Updated 04/30/2010 This study was conducted with women (n=146) in two healthcare facilities in Person County (a rural
More informationHUMAN PAPILLOMAVIRUS (HPV) VACCINE IMPACT AND ALASKA RESEARCH
HUMAN PAPILLOMAVIRUS (HPV) VACCINE IMPACT AND ALASKA RESEARCH MCH Immunization Conference September 24, 2014 Thomas Hennessy MD Arctic Investigations Program CDC Rosalyn Singleton MD State of Alaska Epidemiology;
More informationHEALTH DISPARITIES IN KOREAN AMERICANS
HEALTH DISPARITIES IN KOREAN AMERICANS David Seil Kim, MD, PhD, MBA Department of OBGYN, Cedars-Sinai Medical Center Assistant Clinical Professor, David Geffen School of Medicine, UCLA KAGMA Korean American
More informationAddressing Asthma Disparities from a State s Perspective. Francesca Lopez, MSPH, AE-C Program Manager Georgia Asthma Control Program
Addressing Asthma Disparities from a State s Perspective Francesca Lopez, MSPH, AE-C Program Manager Georgia Asthma Control Program Mission of the Georgia Asthma Control Program To improve asthma control
More informationNIH Public Access Author Manuscript Vaccine. Author manuscript; available in PMC 2014 September 13.
NIH Public Access Author Manuscript Published in final edited form as: Vaccine. 2013 September 13; 31(40): 4436 4441. doi:10.1016/j.vaccine.2013.06.092. Organizational correlates of adolescent immunization:
More informationWho Gets a Provider Recommendation? Reducing Missed Opportunities to. Promote the HPV Vaccine to Male and Female Teens in the U.S.
Krakow 1 Who Gets a Provider Recommendation? Reducing Missed Opportunities to Promote the HPV Vaccine to Male and Female Teens in the U.S. Melinda Krakow, Ph.D., MPH Candidate Johns Hopkins Bloomberg School
More informationHpv Type Distribution In New Haven County, Ct Among Women With Cin2+ Diagnoses From
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2012 Hpv Type Distribution In New Haven County, Ct Among Women With Cin2+
More informationSelling Parents on HPV Vaccination for Their Preteens: You Are The Key
Selling Parents on HPV Vaccination for Their Preteens: You Are The Key November 7, 2014 Jill B Roark, MPH Lead, Adolescent Immunization Communications Health Communication Science Office National Center
More informationObjectives. Selling Parents on HPV Vaccination for Their Preteens: You Are The Key. HPV Facts TOP TEN List. Disclosure
11/12/214 Objectives Selling Parents on HPV Vaccination for Their Preteens: You Are The Key November 7, 214 Jill B Roark, MPH Lead, Adolescent Immunization Communications Health Communication Science Office
More informationImmediate Past President National Medical Association
Improved Survival but Continued Disparities in Cancer: The 1971 National Cancer Act through Moonshot 2017 Edith Peterson Mitchell, MD, FACP, FCPP Clinical Professor of Medicine and Medical Oncology Department
More informationHPV Vaccines. What is HPV? Can a vaccine help prevent HPV?
What is HPV? HPV Vaccines HPV is short for human papilloma virus. HPVs are a group of more than 150 related viruses. Each HPV virus in the group is given a number, which is called an HPV type. HPVs are
More information2017 Vaccination Update
2017 Vaccination Update NATHAN BOONSTRA, MD General Pediatrician, Blank Pediatric Clinic TODAY S OBJECTIVES Review the latest recommendations for immunizations, including HPV Meningococcal vaccines Influenza
More informationVaccine knowledge, attitudes, and informationseeking behavior of parents of adolescents: United States, 2012
Vaccine knowledge, attitudes, and informationseeking behavior of parents of adolescents: United States, 2012 Allison Kennedy Fisher, MPH Katherine LaVail, PhD National Conference on Health Communication,
More informationFactors Associated with Initial Treatment for Clinically Localized Prostate Cancer
Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer Preliminary Results from the National Program of Cancer Registries Patterns of Care Study (PoC1) NAACCR Annual Meeting
More informationHearing Physicians Views: HPV Immunization National Trends Survey (HPV HINTS)
Hearing Physicians Views: HPV Immunization National Trends Survey (HPV HINTS) Susan T. Vadaparampil, Ph.D. Neal Halsey, M.D. Tina Proveaux, B.S. Teri Malo, Ph.D. NIH Grant # R01AI076440-01A1 Funding Period:
More informationSetting the Context: Understanding the Numbers, Vulnerable Populations and Federal Public Health Policy
Setting the Context: Understanding the Numbers, Vulnerable Populations and Federal Public Health Policy David B. Johnson STD Disparities Coordinator, Division of STD Prevention National Center for HIV/AIDS,
More informationDeterminants of U.S. Parental Attitudes and Behavior towards Preventing Cancer in Young Girls through Vaccine
Determinants of U.S. Parental Attitudes and Behavior towards Preventing Cancer in Young Girls through Vaccine Analysis of a National Survey on Human Papillomavirus Vaccine Use Prepared by: Jenna Wright
More informationAn update on the Human Papillomavirus Vaccines. I have no financial conflicts of interest. Case 1. Objectives 10/26/2016
An update on the Human Papillomavirus Vaccines Karen Smith-McCune Professor, UCSF Department of Obstetrics, Gynecology and Reproductive Sciences John Kerner Endowed Chair I have no financial conflicts
More informationA total of 30,115 new cases of HPV-associated cancers were reported in 1999 and 43,371 in 2015.
A total of 30,115 new cases of HPV-associated cancers were reported in 1999 and 43,371 in 2015. Oropharyngeal squamous cell carcinoma is now the most common HPV-associated cancer. During 1999 2015 cervical
More informationIn the trenches: A quality improvement project to improve HPV vaccine completion rates in an urban pediatric practice
In the trenches: A quality improvement project to improve HPV vaccine completion rates in an urban pediatric practice Practical Strategies for Improving HPV Vaccine Coverage Larissa Meyer, MD, MPH Assistant
More informationGive it a Shot with Gardasil. Lauren Haddow. University of Kansas School of Nursing
Give it a Shot with Gardasil Lauren Haddow University of Kansas School of Nursing About the author: A native of Springfield, Missouri, Lauren is a member of Delta Chapter Sigma Theta Tau International.
More informationNIH Public Access Author Manuscript Sex Transm Dis. Author manuscript; available in PMC 2012 March 1.
NIH Public Access Author Manuscript Published in final edited form as: Sex Transm Dis. 2011 March ; 38(3): 197 204. doi:10.1097/olq.0b013e3181f12dbf. Longitudinal Predictors of HPV Vaccine Initiation among
More informationSUPPORT FOR SCHOOL- BASED SEXUALITY EDUCATION: NO LONGER JUST FOR HIGH SCHOOL STUDENTS. Michele J Moore, Elissa Barr, Tammie Johnson
SUPPORT FOR SCHOOL- BASED SEXUALITY EDUCATION: NO LONGER JUST FOR HIGH SCHOOL STUDENTS Michele J Moore, Elissa Barr, Tammie Johnson Presenter Disclosures Elissa M. Barr, PhD (1) The following personal
More informationWhat Parents Should Know
What Parents Should Know Exploring the Link between HPV and Cancer www.indianacancer.org What is HPV? The Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). An STI is a
More informationProtect yourself: Get screened for breast cancer
B Protect yourself: Get screened for breast cancer reast cancer is the most common form of cancer in women with the exception of skin cancer. Women should get annual exams from their healthcare provider
More informationChanges in Caries in Primary Dentition from to Among U.S. Children Aged 2-5 Years: A Closer Look
Changes in Caries in Primary Dentition from 1988-1994 to 1999-2004 Among U.S. Children Aged 2-5 Years: A Closer Look Laurie Barker, MSPH Mathematical Statistician Presenting for Mei Lin, MD, MPH, MS, Epidemiologist
More informationTable of Contents. 2 P age. Susan G. Komen
RHODE ISLAND Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 4 Quantitative Data: Measuring
More informationHPV Vaccination Challenges in Rural and Suburban Settings. Deanna Kepka, PhD, MPH College of Nursing Huntsman Cancer Institute University of Utah
HPV Vaccination Challenges in Rural and Suburban Settings Deanna Kepka, PhD, MPH College of Nursing Huntsman Cancer Institute University of Utah Meet Mandy Objectives Present overview of HPV, HPV cancers,
More informationABSTRACT. Olivia Carter-Pokras, Ph.D. Department of Epidemiology and Biostatistics
ABSTRACT Title of Document: FACTORS ASSOCIATED WITH COMPLETION OF THE HUMAN PAPILLOMAVIRUS VACCINE SERIES AMONG HISPANIC AND NON-HISPANIC WHITE ADOLESCENT GIRLS IN THE UNITED STATES Maria Teresa Demarco,
More informationQuantitative Data: Measuring Breast Cancer Impact in Local Communities
Quantitative Data: Measuring Breast Cancer Impact in Local Communities Quantitative Data Report Introduction The purpose of the quantitative data report for the Southwest Florida Affiliate of Susan G.
More informationUsing Patient Navigation to Impact Trust in the Health Care System
Using Patient Navigation to Impact Trust in the Health Care System ARANTZA RODRIGUEZ PUERTOS MENTOR: CARMEN E. GUERRA, M.D., M.S.C.E., F.A.C.P. Introduction Data and Methods Outline Key Findings and Discussion
More informationAchieving High Adolescent HPV Vaccination Coverage. ANNA- LISA M. FARMAR, MD, MPH National Vaccine Advisory Committee Meeting February 7, 2018
Achieving High Adolescent HPV Vaccination Coverage ANNA- LISA M. FARMAR, MD, MPH National Vaccine Advisory Committee Meeting February 7, 2018 DISCLOSURES 2 I have no actual or potential conflicts of interest
More informationLessons Learned from HPV Vaccine Study Among Young Adult Women and Men
Lessons Learned from HPV Vaccine Study Among Young Adult Women and Men Natalie Joseph, MD, MPH Assistant Professor of Pediatrics/Adolescent Medicine Boston University Medical Center Racial and ethnic differences
More informationTable of Contents. 2 P a g e. Susan G. Komen
NEW HAMPSHIRE Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 4 Quantitative Data: Measuring
More informationHealth Cognition & Behavior Lab
Health Cognition & Behavior Lab Adolescent Vaccination in Pharmacies Survey (2015) Updated 07/21/2015 This survey was designed by Noel Brewer, Macary Marciniak, and colleagues at the UNC Gillings School
More informationWhat You Should Know. Exploring the Link between HPV and Cancer.
What You Should Know Exploring the Link between HPV and Cancer www.indianacancer.org What is HPV? The Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). An STI is a virus
More informationDesigning a Community-Based Intervention to Improve the Health of Medically-Underserved Women with Systemic Lupus Erythematosus
Designing a Community-Based Intervention to Improve the Health of Medically-Underserved Women with Systemic Lupus Erythematosus Candace H Feldman MD, MPH Patricia Fraser MD Melanie Zibit MEd, MBA Derrick
More informationGeographic Variation of Advanced Stage Colorectal Cancer in California
Geographic Variation of Advanced Stage Colorectal Cancer in California Jennifer Rico, MA California Cancer Registry California Department of Public Health NAACCR 2016- St. Louis, MO June 16, 2016 Overview
More informationEvidence-Based HPV Disease Prevention HPV VACCINE
Evidence-Based HPV Disease Prevention HPV VACCINE Educating and normalizing vaccine compliance for the teen population Leisha Nolen, MD PhD Enroll in Electronic Poll System In the texting app in your phone:
More informationADDRESSING HUMAN PAPILLOMAVIRUS VACCINATION RATES IN THE YEAR OLD AGE GROUP THROUGH IMPROVED PROVIDER RECOMMENDATION.
ADDRESSING HUMAN PAPILLOMAVIRUS VACCINATION RATES IN THE 11-12 YEAR OLD AGE GROUP THROUGH IMPROVED PROVIDER RECOMMENDATION Erica Harberger A project submitted to the faculty at the University of North
More informationWHY WE RE HERE. Melinda Wharton, MD, MPH Director, Immunization Services Division. National Center for Immunization & Respiratory Diseases
National Center for Immunization & Respiratory Diseases WHY WE RE HERE Melinda Wharton, MD, MPH Director, Immunization Services Division AIM Leadership Conference February 8, 2017 Vaccines save lives.
More informationQuestions and answers about HPV. Facts about the virus and the vaccine
Questions and answers about HPV Facts about the virus and the vaccine About the introduction of the human papillomavirus (HPV) vaccine Which countries have introduced the HPV vaccine? Over 100 countries
More informationHEALTH DISPARITIES AMONG ADULTS IN OHIO
OHIO MEDICAID ASSESSMENT SURVEY 2012 Taking the pulse of health in Ohio HEALTH DISPARITIES AMONG ADULTS IN OHIO Amy K. Ferketich, PhD 1 Ling Wang, MPH 1 Timothy R. Sahr, MPH, MA 2 1The Ohio State University
More informationAre You Ready to Sail. February 11, 2016
Are You Ready to Sail your SHIP?! February 11, 2016 Acknowledgement and Disclaimer This webinar was supported by funds made available from the Centers for Disease Control and Prevention, Office for State,
More informationAccelerating Uptake of the Human Papillomavirus (HPV) Vaccine in Inland Northern California
Accelerating Uptake of the Human Papillomavirus (HPV) Vaccine in Inland Northern California Julie Dang, PhD, MPH Administrative Director, Community Engagement and Outreach Duke LeTran, BS, Catrina Franco,
More informationPertussis in California: The changing landscape of prevention and control
Pertussis in California: The changing landscape of prevention and control Kathleen Winter, PhD, MPH Rebeca Boyte, MAS Immunization Branch California Department of Public Health Pertussis (whooping cough)
More informationHealth care reform: Continuing the prostate screening debate; Where does patient navigation belong?
University of Arkansas for Medical Sciences From the SelectedWorks of Michael Preston November 4, 2013 Health care reform: Continuing the prostate screening debate; Where does patient navigation belong?
More informationHPV Vaccine Ina Park, MD, MS
HPV Vaccine Ina Park, MD, MS California Department of Public Health STD Control Branch Alameda County Immunization Update 2014 Over 170 types of HPV classified Updated incidence/prevalence estimates (CDC):
More informationMaking the connections Washington families need to be healthy. Preventing HPV Cancers: A Distance-Learning Course in Washington
Making the connections Washington families need to be healthy. Preventing HPV Cancers: A Distance-Learning Course in Washington Why a continuing education course on recommending HPV immunization? HPV immunization
More informationORIGINAL REPORTS: PUBLIC HEALTH
ORIGINAL REPORTS: PUBLIC HEALTH THE IMPACT OF SOCIAL COMMUNICATION ON PERCEIVED HPV VACCINE EFFECTIVENESS IN A LOW-INCOME, MINORITY POPULATION Objectives: Perceived vaccine effectiveness is linked to vaccine-uptake.
More informationMeasuring Equitable Care to Support Quality Improvement
Measuring Equitable Care to Support Quality Improvement Berny Gould RN, MNA Sr. Director, Quality, Hospital Oversight, and Equitable Care Prepared by: Sharon Takeda Platt, PhD Center for Healthcare Analytics
More informationOral Health of New Brunswick s Children
Oral Health of New Brunswick s Children Data from the Healthier New Brunswick Community Survey The New Brunswick Health Task Force & Community Health Advisory Group Meeting Thursday September 14, 2006
More informationHPV in the U.S.- Where are we now?
HPV in the U.S.- Where are we now? Heather M. Limper, MPH, PhD Candidate hlimper@medicine.bsd.uchicago.edu Conflicts of Interest I have no disclosures to make of any conflicts of interest associated with
More informationLess Is More Utilizing Appropriate Messaging to
Less Is More Utilizing Appropriate Messaging to Increase HPV Rates Marcia Levin, MPH VFC Program Manager City of Chicago Mayor Rahm Emanuel Chicago Department of Public Health Commissioner Bechara Choucair,
More informationTable of Contents. 2 P age. Susan G. Komen
NEVADA Table of Contents Table of Contents... 2 Introduction... 3 About... 3 Susan G. Komen Affiliate Network... 3 Purpose of the State Community Profile Report... 4 Quantitative Data: Measuring Breast
More informationMandatory HPV Vaccination: An Ethical Analysis
Volume 2 Number 1 (Spring/Summer 2016) www.jheaonline.org. ARTICLE Mandatory HPV Vaccination: An Ethical Analysis This article appeared originally in The Internet Journal of Catholic Bioethics (Winter
More informationApril Blackmon NURS7440/7550. Gardasil. Auburn University/Auburn Montgomery
April Blackmon Health Promotion Paper NURS7440/7550 Gardasil Auburn University/Auburn Montgomery 2 Introduction Human papillomavirus or HPV is a virus that will affect an estimated 75%- 80% of males and
More informationabstract ARTICLE increase in HPV vaccine initiation among young adolescents. NIH
Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial Noel T. Brewer, PhD, a, b Megan E. Hall, MPH, a Teri L. Malo, PhD, b Melissa B. Gilkey, PhD, c Beth Quinn, BS,
More informationComparison of immunogenicity of 2-dose and 3-dose regimens of 9-valent HPV vaccine Advisory Committee on Immunization Practices 24-Feb-2016
1 Comparison of immunogenicity of 2-dose and 3-dose regimens of 9-valent HPV vaccine Advisory Committee on Immunization Practices 24-Feb-2016 Presenter: Alain Luxembourg, MD, PhD Director, Clinical Research
More information